This month, Dr Myers talks about two major issues in the relationship between prostate cancer and bone. First, bone is a primary site to which metatatic prostate cancer spreads. He discuss treatment … more

This month, we’re talking about our understanding of the genetic and molecular mechanisms driving prostate cancer. If we can understand how cancer differs from your body’s normal tissues, we can … more

It is almost impossible to think of prostate cancer without considering cardiovascular disease. Cardiovascular disease is a major cause of morbidity and mortality   in men over the age of 60—the age … more

This month we’re talking about  advances in prostate cancer  immunotherapy. The interviews  are informative and lucid—  quite an achievement as cancer  immunotherapy is quite complex.  One important … more

Treating recurrent prostate cancer is a major focus in my clinic, the American Institute for Diseases of the Prostate (AIDP). I started seeing patients with recurrent disease in 1994 at the … more

This issue, one of our largest, is devoted to active surveillance. There are multiple reasons for the extensive set of interviews contained in this issue. First, most men diagnosed with prostate … more

Dr. Myers talks about with the use of MRI as opposed to transrectal ultrasoud has significantly change the way that radical prostatectomy. There are many studies showing the advantage of using MRI. … more